Go Capital holds interim close for Amorçage II

The vehicle previously held a first close in May 2017 on €60m and originally targeted a final close on €80-100m by the second half of 2017. 

In October 2017, Go Capital hired Emmanuelle Deponge and Jean-Marc Herbert as venture partners, responsible for portfolio management and investment sourcing in the life sciences sector.

The first Go Capital seed fund held a final close on €57m in June 2013 and finished its investment period in 2017 after making 25 equity investments.

Investors
The vehicle's first close saw a mix of national and international funds, industrial companies, national entities, banks and business angels committing to the fund. State-backed BPI France committed €20m via the National Seed Fund, alongside the European Investment Fund, which backed it for the same amount. Additionally, multiple banks, regional councils (Pays de la Loire, Bretagne and Normandie) and around 20 independent investors backed the vehicle.

The interim close includes new commitments from BPI France, regional councils, public entities such as Nantes Métropole and Rennes Métropole, the VC firm Arkea Capital and around 10 business angels.

Investments
The fund will provide an average of €400,000 for initial investments, up to €2m in further rounds and up to €6m per project in total. For more capital-intensive projects, first round co-investments will be considered.

Go Capital Amorçage II invests in companies in the pre-development stage of their commercial offering across a broad range of sectors, including healthcare, technology, renewable energy and business services.

To date, Go Capital Amorçage II has invested in 10 businesses. Some of its most recent investments include France-based Tricares, a specialist in tricuspid regurgitation treatment, and biotech business Pherecydes Pharma.

People
Go Capital – Eric Cozanet (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Venture
• France
• France